Evidence map›Paper›PMID 32318442›Full record

ArticleJournal of family medicine and primary care2020

Treatment response in elderly patients with advanced colorectal cancer at King Abdulaziz Medical City, Princess Norah Oncology Center, Jeddah.

Abdullah Nasser Leslom, Fahad Juwayid Alqahtani, Abdulbari Ahmed Saeed Hanash, Abdullah Abdulhadi Alsubaie, Mohammed Saeed Alamri

Open access · goldAbstract read
In one paragraph

Article in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abdullah Nasser LeslomIntern, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Fahad Juwayid AlqahtaniIntern, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Abdulbari Ahmed Saeed HanashIntern, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Abdullah Abdulhadi AlsubaieMedical Student, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Mohammed Saeed AlamriIntern, College of Medicine, King Khalid University, Abha, Saudi Arabia.
King Khalid University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal carcinoma is the most evident carcinoma in the elderly. Despite its high incidence and mortality rate, there is insufficient research about the best treatment options for colorectal carcinoma.

objectiveThis study was designed to assess the best treatment modality for colorectal carcinoma in elderly Saudi patients.

methodsWe conducted a retrospective analysis of medical records at the Princess Norah Oncology Center (PNOC), King Abdulaziz Medical City, Jeddah, Saudi Arabia. We included patients treated at PNOC between 2010 and 2015. Only patients aged above 70 years with advanced colon were included in the study.

resultsThe cohort included 57 patients with an average age of 76.51 with 27 alive patients and 30 dead patients. Nonmucinous adenocarcinoma had significant higher mortality (

conclusionLocal radiotherapy and local liver ablation had the least mortality rate. However, in multivariate Cox regression analysis, we found that shift to next line of treatment was associated with the significant high survival rate.

Indexed as

Colorectal cancercolorectal carcinomaelderlySaudi Arabiasurvival rates

Identifiers

PMID32318442
PMCPMC7114059
OpenAlexW3010187218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.